(Q39041221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Sebastian Schneeweiss

32

object named as

S Schneeweiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

H-G Eichler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L G Baird

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Barker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B Bloechl-Daum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

F Børlum-Kristensen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Brown

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Chua

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Del Signore

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

U Dugan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Ferguson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Garner

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

W Goettsch

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Haigh

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

P Honig

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Hoos

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

P Huckle

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T Kondo

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Y Le Cam

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

H Leufkens

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Lim

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Longson

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Lumpkin

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Maraganore

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B O'Rourke

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

K Oye

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Pezalla

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

F Pignatti

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Raine

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Rasi

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T Salmonson

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D Samaha

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

P D Siviero

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Skinner

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J R Teagarden

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T Tominaga

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M R Trusheim

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Tunis

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T F Unger

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Vamvakas

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Hirsch

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

4 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

234-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

Health technology assessment, value-based decision making, and innovation

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Balancing societal needs and regulatory certainty: the case study of peramivir in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Adaptive licensing: taking the next step in the evolution of drug approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

The risks of risk aversion in drug regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

A free-market approach to clinical data gathering is more ethical.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Regulation: Sell help not hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Designing transformative clinical trials in the cancer genome era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

'Basket studies' will hold intricate data for cancer drug approvals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Regulatory innovation and drug development for early-stage Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Clinical development success rates for investigational drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

21 January 2018

The calculus of cures

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Deming, data and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Learning from big health care data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Mini-Sentinel and regulatory science--big data rendered fit and functional

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Launching PCORnet, a national patient-centered clinical research network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Railways, industry, and surgery--the introduction of risk management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

Strategies for the economic evaluation of end-of-life care: making a case for the capability approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCPT.59

A third seat at the table: an insider's perspective on patient representatives

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25669457

12 December 2020

Evidence vs. Access: Can Twenty-First-Century Drug Regulation Refine the Tradeoffs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25669457

12 December 2020

Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices

1 reference

https://pubmed.ncbi.nlm.nih.gov/25669457

12 December 2020

Canadian health ministry is given new powers to tighten drug safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/25669457

12 December 2020

Accelerated access to innovative medicines for patients in need

1 reference

https://pubmed.ncbi.nlm.nih.gov/25669457

12 December 2020

Risk Management Plans as a Tool for Proactive Pharmacovigilance: A Cohort Study of Newly Approved Drugs in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/25669457

12 December 2020

Identifiers

DOI

10.1002/CPT.59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

25669457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25669457%20AND%20SRC:MED&resulttype=core&format=json